Compounded Medication for a Pet: A Quality Checklist Before You Fill It
“Why compound this patient’s prescription?” is the first question to ask—not which flavor to choose or which pharmacy charges less. A compounded medication may meet a specific need that available products cannot, but the finished compounded preparation is not FDA-approved, even when it starts with an approved drug.
Before filling a prescription, collect the patient-specific reason, ingredient source, exact formulation, pharmacy details, handling instructions, and problem-reporting plan. This checklist is for US nonfood-producing pets; animals that produce meat, milk, or eggs require additional considerations.
Establish the patient-specific reason
Compounding combines, mixes, or alters ingredients to make a medication tailored to an animal’s needs. FDA recognizes situations in which a different flavor, concentration, dosage form, or ingredient profile may be medically necessary.
The useful explanation connects a particular feature of your pet to a particular limitation of the available product. “My pet needs a liquid because tablets cannot be administered reliably” is more informative than “compounded medications are easier.”
Ask the prescribing veterinarian:
-
Which specific need does this preparation address?
-
Why will an available FDA-approved, conditionally approved, or indexed product not meet that need?
-
What difference should the compounded preparation make for this patient?
-
Does the prescription identify my pet and the intended formulation?
-
If bulk ingredients are used to make a copy of an available product, has the required patient-specific clinical rationale been communicated to the compounder?
For certain compounded copies made from bulk drug substances, FDA’s Guidance for Industry #256 describes documentation of the veterinarian’s clinical rationale. That rationale must originate from the treating veterinarian; the pharmacy should not invent it. The compounder also documents why an approved or indexed product cannot serve as the ingredient source.
An owner’s checklist supports this conversation. It does not replace the veterinarian’s medical record or the pharmacy’s compounding records.
Identify the source and supply
Two preparations containing the same named ingredient can start from different materials. Ask which source category applies to your prescription.
Compounding from approved drugs can be permitted under AMDUCA and its extra-label-use regulations when the applicable conditions are met, including a lawful veterinarian order within a valid veterinarian-client-patient relationship.
For bulk-compounded animal drugs, GFI #256 describes circumstances in which FDA generally does not intend to take enforcement action. This enforcement discretion is not approval and does not establish equivalence to an approved product.
Ask why a finished approved product cannot be used if bulk material is proposed. A supplier’s certificate of analysis may provide information about an ingredient, but it does not establish FDA approval or verify the quality of the finished preparation dispensed to your pet.
Patient-specific versus office stock
A patient-specific prescription identifies the animal that needs treatment when the prescription is written. Office stock is medication kept in a veterinarian’s inventory for animals that may need treatment later.
For bulk-compounded office stock, FDA’s policy involves additional circumstances, including urgent treatment needs and applicable lists specifying substances, species, formulations, and uses. A substance’s presence on a list is not blanket authorization for every preparation containing it.
If the clinic supplies a compounded medication already on hand, ask who compounded it, how it is identified, and which instructions apply to your pet. The veterinarian and compounder—not the owner—must determine whether the relevant federal and state conditions are met.
Complete the pre-fill checklist
Use these grouped checks to record the answers you receive. They are practical verification questions, not a claim that every item is a universally required label element. Federal guidance and state pharmacy or veterinary rules may differ.
Prescriber and patient
-
Record your pet’s name, species, and identifying information.
-
Record the prescribing veterinarian’s name, clinic, and contact number.
-
Write the patient-specific reason for compounding and why available products are unsuitable.
-
Confirm that the pharmacy has the veterinarian’s current prescription and has resolved any discrepancy.
-
If bulk ingredients are used, record the explanation for not using an appropriate finished product as the source.
Product identity
-
Copy the complete active-ingredient name, including the salt form when relevant.
-
Identify the source as a finished approved drug or a bulk drug substance.
-
Record the dosage form, such as solution, suspension, capsule, or topical preparation.
-
Copy the exact strength or concentration and units from the prescription and proposed label.
-
Confirm that the route and quantity agree with the prescription.
-
Ask which flavorings, sweeteners, preservatives, vehicles, or other inactive ingredients are present.
-
For a measured liquid, confirm that the supplied device and its markings match the written instructions.
Flavoring and other inactive ingredients are part of the formulation, not merely cosmetic additions. AVMA notes that such ingredients can cause intolerance or other problems in particular animals. Ask the pharmacist and veterinarian to resolve species-specific or patient-specific concerns rather than selecting ingredients yourself.
A different concentration, dosage form, or route is a prescription discrepancy to clarify—not a reason to calculate a conversion or substitute another preparation.
Pharmacy and quality documentation
-
Record the dispensing pharmacy or clinic’s name, address, and telephone number.
-
If a different facility compounds the medication, record its name and contact details.
-
Retain relevant pharmacy license information and verify it through the state board of pharmacy when applicable.
-
Ask what evidence supports this particular formulation, its storage conditions, and its assigned beyond-use date.
-
Ask which quality checks apply to this preparation and what they establish.
-
Record the prescription number and any lot, batch, or preparation identifier supplied.
-
Confirm how the pharmacy will contact you if a recall or quality problem affects the preparation.
A general statement such as “we test our medications” may refer to an ingredient supplier, another formulation, or the finished preparation. Ask which one applies. No single test, license, or accreditation guarantees safety or effectiveness.
Label and handling
-
Confirm that the label matches the patient, ingredient, strength or concentration, route, and veterinarian’s directions.
-
Record the assigned beyond-use date.
-
Obtain written storage instructions, including temperature and light protection when relevant.
-
Confirm any formulation-specific handling directions, such as whether shaking is required.
-
Keep the supplied container and confirm how to use the intended measuring device.
-
Ask whom to contact if the package arrives damaged or outside the stated handling conditions.
-
Confirm that the dispensed quantity can be used within the assigned beyond-use period under the prescribed plan.
A compounded preparation’s beyond-use date is not the same as the manufacturer’s expiration date on the source drug. AVMA recommends asking the pharmacist how the beyond-use date was established. Do not assume the compounded preparation inherits the source product’s shelf life or storage instructions.
An unexpected color change, precipitation, or separation can warrant a pharmacy review. Some suspensions normally settle, so ask what appearance is expected for your exact formulation rather than judging all liquids by the same rule.
Retain the record and contacts
Keep the prescription information, completed checklist, label photographs, dispensing receipt, and written formulation or handling information together. Your retained packet should let the veterinarian or pharmacist identify the preparation without relying on memory.
Complete this handoff record before leaving the pharmacy or accepting delivery.
Ask the veterinarian what response to treatment will be assessed, what adverse effects matter for the prescribed medication, and when follow-up is needed. These answers depend on the drug and patient; a generic compounding checklist cannot supply them.
If a suspected adverse reaction occurs, contact the prescribing veterinarian and pharmacist promptly. An urgent clinical reaction requires immediate veterinary or emergency-service assessment rather than waiting for a pharmacy quality investigation.
For a suspected product defect, retain the container, labeling, preparation identifier, and relevant photographs. Ask the pharmacist and veterinarian to advise on the medication-use decision and investigation. Do not alter the formulation, adjust the dose, or independently change an ongoing treatment plan.
Owners and veterinarians can report suspected adverse events or product problems to FDA. GFI #256 recommends reporting by compounders, but this is not the same as the routine mandatory reporting system that applies to approved animal-drug sponsors. Reporting a problem does not require proving that the compounded medication caused it.
Before filling, identify any unresolved prescription, source, concentration, storage, or beyond-use information and assign it to the veterinarian or pharmacist for clarification. If timing could affect treatment, contact the prescriber promptly so the documentation question does not become an unmanaged delay in care.